Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis
K Kley, P Oehr - Anticancer research, 2010 - ar.iiarjournals.org
Background: The synergy between in vitro and in vivo imaging was investigated in this
study. Patients and Methods: Comparison of fluorodeoxyglucose positron-emission …
study. Patients and Methods: Comparison of fluorodeoxyglucose positron-emission …
PET/CT in non-small cell lung cancer staging—promises and problems
A Devaraj, GJR Cook, DM Hansell - Clinical radiology, 2007 - Elsevier
Integrated positron emission tomography/computed tomography (PET/CT) has many
advantages over solitary PET and CT, which has led it to become an increasingly …
advantages over solitary PET and CT, which has led it to become an increasingly …
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
J Wu, H Deng, H Zhong, T Wang, Z Rao, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Purpose Several studies have demonstrated that 68Ga-FAPI PET/CT shows high
intratumoral tracer uptake and low normal tissue uptake, allowing for excellent visualization …
intratumoral tracer uptake and low normal tissue uptake, allowing for excellent visualization …
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging …
SL Aquino, AJ Fischman - Chest, 2004 - Elsevier
Background: Whole-body (WB) positron emission tomography (PET) with 2-[18 F]-fluoro-2-
deoxy-D-glucose (FDG) is more accurate than other imaging studies for detecting lung …
deoxy-D-glucose (FDG) is more accurate than other imaging studies for detecting lung …
Low-sensitivity FDG-PET studies: less common lung neoplasms
JJ Erasmus, HA Macapinlac - Seminars in nuclear medicine, 2012 - Elsevier
Computed tomography (CT) and positron emission tomography (PET) using the
radiopharmaceutical 18F-2-deoxy-d-glucose (FDG) play an important role in the diagnosis …
radiopharmaceutical 18F-2-deoxy-d-glucose (FDG) play an important role in the diagnosis …
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions-results from a large prospective clinical trial
S Pauls, AK Buck, G Halter, FM Mottaghy… - Molecular Imaging and …, 2008 - Springer
Purpose The purpose of the study was to evaluate prospectively whether integrated 2-deoxy-
2-[18 F] fluoro-d-glucose positron emission tomography/computed tomography (FDG …
2-[18 F] fluoro-d-glucose positron emission tomography/computed tomography (FDG …
[HTML][HTML] Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease
GM Graeber, NC Gupta, GF Murray - The Journal of Thoracic and …, 1999 - Elsevier
Objective: Positron emission tomography (PET), when used with the intravenously
administered radiopharmaceutical F-18 fluorodeoxyglucose (FDG), has the potential to help …
administered radiopharmaceutical F-18 fluorodeoxyglucose (FDG), has the potential to help …
Determination of the prognostic value of [18F] fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer
HJ Jeong, JJ Min, JM Park, JK Chung… - Nuclear medicine …, 2002 - journals.lww.com
The aim of this study was to determine whether quantitative information obtained from [18 F]
fluorodeoxyglucose positron emission tomography (18 F-FDG PET) has a prognostic …
fluorodeoxyglucose positron emission tomography (18 F-FDG PET) has a prognostic …
Prognosis and reevaluation of lung cancer by positron emission tomography imaging
JJ Erasmus, E Rohren, SG Swisher - Proceedings of the American …, 2009 - atsjournals.org
Positron emission tomography (PET) imaging using 18F-2-deoxy-D-glucose, a D-glucose
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …
Impact of whole‐body 18F‐fluorodeoxyglucose positron emission tomography on therapeutic management of non‐small cell lung cancer
EY Heo, SC YANG, CG YOO, SK Han, YS SHIM… - …, 2010 - Wiley Online Library
Background and objective: Accurate staging at the time of diagnosis is very important in
deciding on the appropriate treatment for cancer patients. FDG PET indicates metabolic …
deciding on the appropriate treatment for cancer patients. FDG PET indicates metabolic …